Panacea Biotec’s promoters to demerge real estate business into separate firm

31 Aug 2017 Evaluate

Panacea Biotec’s promoters have entered into a family agreement under which they plan to demerge the company’s real estate business into a separate firm. The company’s real estate arm, Radhika Heights, would be managed by Ravinder Jain and may become a separate listed entity. On the other hand, the pharmaceutical formulation and vaccine business will continue to be managed by promoters Soshil Kumar Jain, Rajesh Jain and Sandeep Jain.

The promoters -- Soshil Kumar Jain, Ravinder Jain, Rajesh Jain and Sandeep Jain have entered into a Memorandum of Acknowledgement of Oral Family Settlement (Memorandum) with regard to the overall control and management of the company and its subsidiaries.

Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and leading Biotechnology Companies in India.

Panacea Biotec Share Price

364.20 -4.40 (-1.19%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×